↓ Skip to main content

Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice

Overview of attention for article published in Breast Cancer Research, March 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#14 of 1,765)
  • High Attention Score compared to outputs of the same age (98th percentile)

Mentioned by

news
24 news outlets
twitter
22 tweeters

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice
Published in
Breast Cancer Research, March 2021
DOI 10.1186/s13058-021-01409-8
Pubmed ID
Authors

Angela DeMichele, Massimo Cristofanilli, Adam Brufsky, Xianchen Liu, Jack Mardekian, Lynn McRoy, Rachel M. Layman, Birol Emir, Mylin A. Torres, Hope S. Rugo, Richard S. Finn

Twitter Demographics

The data shown below were collected from the profiles of 22 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 28%
Other 6 19%
Student > Doctoral Student 2 6%
Student > Ph. D. Student 2 6%
Student > Master 2 6%
Other 4 13%
Unknown 7 22%
Readers by discipline Count As %
Medicine and Dentistry 6 19%
Pharmacology, Toxicology and Pharmaceutical Science 5 16%
Nursing and Health Professions 2 6%
Business, Management and Accounting 1 3%
Mathematics 1 3%
Other 4 13%
Unknown 13 41%

Attention Score in Context

This research output has an Altmetric Attention Score of 174. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2021.
All research outputs
#140,943
of 18,881,749 outputs
Outputs from Breast Cancer Research
#14
of 1,765 outputs
Outputs of similar age
#4,729
of 323,147 outputs
Outputs of similar age from Breast Cancer Research
#1
of 1 outputs
Altmetric has tracked 18,881,749 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,765 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,147 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them